Ocimum Biosolutions Ltd. is a research and development enabling research services organization that provides complete outsourced solutions in genomics and molecular biology. Ocimum’s strength lies in its people, processes and products, such as BioIT, to provide complete solutions for its customers. Ocimum offers research tools, reagents, and services to Big Pharma, academia, research centers, and biotech companies. IFC is supporting the company’s global growth strategy, based on acquisitions, investments, and training of new scientists.
IFC role and development impact:
- $6.5 million in equity financing for the company’s global expansion strategy
- Supporting transfer of modern technology by integrating acquisitions of biotechnology companies in developing countries with the company’s operations in India
- Supporting development of intellectual capital by training scientists working on human health
